Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry

• Үндсэн зохиолчид: Jun Young Lee (Зохиогч), Sung Hwa Kim (Зохиогч), Yeon Ho Park (Зохиогч), Jae Berm Park (Зохиогч), Su Hyung Lee (Зохиогч), Jaeseok Yang (Зохиогч), Myoung Soo Kim (Зохиогч), Deok Gie Kim (Зохиогч)
• Формат: Ном
• Хэвлэсэн: The Korean Society of Nephrology, 2022-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Background Basiliximab (BSX) and antithymocyte globulins (ATGs), are two major immunosuppressive agents commonly used as induction therapy for kidney transplant (KT) recipients. The superiority of ATG over BSX has not been well established, especially in elderly KT recipients with low immunological...